Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	3/16/2007 3:59:58 AM
	Read Replies (1) of 10280

India's Ranbaxy gets tentative US nod for zolpidem MUMBAI, March 16 (Reuters) - India's Ranbaxy Laboratories Ltd. RANB.BO: Quote, Profile , Research) said on Friday it had received tentative approval from the U.S. Food and Drug Administration to manufacture and market zolpidem tartrate tablets, used to treat insomnia. The company said in a statement that its drug was a bioequivalent of Ambien tablets of Sanofi Aventis (SASY.PA: Quote, Profile , Research). Ranbaxy said the drug had annual sales of $2.12 billion.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next